Skip to main content
Log in

Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy

Hochregulation von „mitochondrial coupling factor 6“ bei hypertonieinduzierter kardialer Hypertrophie

  • Original article
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Background

Mitochondrial coupling factor 6 (CF6) is a constriction factor in cardiac hypertrophy, whose mechanisms are not fully understood.

Materials and methods

Here, we established cardiac hypertrophy models for feeding spontaneously hypertensive rats (SHRs) aged 10, 20, and 30 weeks. Hemodynamic monitoring was performed during the feeding program to ensure the success of the model.

Results

Cardiac hypertrophy, but not fibrosis, occurred in the 10-, 20-, and 30-week-old SHRs. No significant changes in CF6 gene expression were detected by RT-PCR in any of the SHR groups as compared with the control groups (p > 0.05). ELISA assessment showed that the CF6 protein level in the 20- and 30-week-old SHRs with cardiac hypertrophy was significantlyincreased (vs. control, p < 0.05).

Conclusion

CF6 protein was upregulated in cardiac hypertrophy induced by hypertension; further mechanisms involved in this process should be investigated.

Zusammenfassung

Hintergrund

„Mitochondrial coupling factor 6“ (CF6) ist ein Konstriktionsfaktor bei kardialer Hypertrophie, dessen Wirkweise noch nicht vollständig bekannt ist.

Methoden

In der vorliegenden Arbeit entwickelten die Autoren Modelle kardialer Hypertrophie mit Fütterung spontan hypertensiver Ratten (SHR) im Alter von 10, 20 und 30 Wochen. Das hämodynamische Monitoring erfolgte im Rahmen des Fütterungsschemas, um den Erfolg des Modells zu sichern.

Ergebnisse

Es trat eine kardiale Hypertrophie, nicht aber eine Fibrose bei den 10, 20 und 30 Wochen alten SHR auf. Signifikante Veränderungen der CF6-Gen-Expression wurden mittels RT-PCR bei den 10, 20 und 30 Wochen alten SHR im Vergleich zu den jeweiligen Kontrollgruppen nicht festgestellt (p > 0,05). Die Untersuchung mittels ELISA ergab, dass der CF6-Protein-Wert bei den 20 und 30 Wochen alten SHR mit kardialer Hypertrophie (gegenüber den Kontrollen; p < 0,05) signifikant erhöht war.

Schlussfolgerung

Das CF6-Protein war bei durch Hypertonie induzierter kardialer Hypertrophie hochreguliert; weitere Abläufe, die an diesem Vorgang beteiligt sind, sollten noch untersucht werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Osanai T, Tanaka M, Kamada T et al (2001) Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest 108:1023–1030

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Osanai T, Saitoh M, Sasaki S et al (2003) Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 42:985–990

    Article  CAS  PubMed  Google Scholar 

  3. Izumiyama K, Osanai T, Sagara S et al (2012) Estrogen attenuates coupling factor 6-induced salt-sensitive hypertension and cardiac systolic dysfunction in mice. Hypertens Res 35:539–546

    Article  CAS  PubMed  Google Scholar 

  4. Sukekawa T, Osanai T, Nishizaki F et al (2013) Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy. Hypertens Res 36:520–527

    Article  CAS  PubMed  Google Scholar 

  5. Sagara S, Osanai T, Itoh T et al (2012) Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice. J Hypertens 30:778–786

    Article  CAS  PubMed  Google Scholar 

  6. Osanai T, Tanaka M, Magota K et al (2012) Coupling factor 6-induced activation of ecto-F1F(o) complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice. Diabetologia 55:520–529

    Article  CAS  PubMed  Google Scholar 

  7. Osanai T, Fujiwara N, Sasaki S et al (2010) Novel pro-atherogenic molecule coupling factor 6 is elevated in patients with stroke: a possible linkage to homocysteine. Ann Med 42:79–86

    Article  CAS  PubMed  Google Scholar 

  8. Osanai T, Magota K, Okumura K et al (2009) Coupling factor 6 as a novel vasoactive and proatherogenic peptide in vascular endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 380:205–214

    Article  CAS  PubMed  Google Scholar 

  9. Osanai T, Tomita H, Yamada M et al (2009) Coupling factor 6-induced prostacyclin inhibition is enhanced in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 27:1823–1828

    Article  CAS  PubMed  Google Scholar 

  10. Echizen T, Osanai T, Ashitate T et al (2009) Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation. Hypertens Res 32:182–187

    Article  CAS  PubMed  Google Scholar 

  11. Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776–781

    Article  CAS  PubMed  Google Scholar 

  12. Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin-II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts-critical role of the at (1) receptor subtype. Circ Res 73:413–423

    Article  CAS  PubMed  Google Scholar 

  13. Drazner MH (2011) The progression of hypertensive heart disease. Circulation 123:327–334

    Article  PubMed  Google Scholar 

  14. Nadruz W (2015) Myocardial remodeling in hypertension. J Hum Hypertens (published 2014/05/08.) doi:10.1038/jhh.2014.36

  15. Cohn JN, Ferrari R, Sharpe N et al (2000) Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569–582

    Article  CAS  PubMed  Google Scholar 

  16. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998

    Article  CAS  PubMed  Google Scholar 

  17. Jia L, Li Y, Xiao C et al (2012) Angiotensin II induces inflammation leading to cardiac remodeling. Front Biosci (Landmark Ed) 17:221–231

    Article  CAS  Google Scholar 

  18. Shahbaz AU, Sun Y, Bhattacharya SK et al (2010) Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies. J Hypertens 28:25–32

    Article  Google Scholar 

  19. Osanai T, Matsumura H, Kikuchi T et al (1990) Changes in vascular wall production of prostacyclin and thromboxane A2 in spontaneously hypertensive rats during maturation and the concomitant development of hypertension. Jpn Circ J 54:507–514

    Article  CAS  PubMed  Google Scholar 

  20. Falardeau P, Robillard M, Martineau A (1985) Urinary levels of 2, 3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. Prostaglandins 29:621–628

    Article  CAS  PubMed  Google Scholar 

  21. Osanai T, Kamada T, Fujiwara N et al (1998) A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 273:31778–31783

    Article  CAS  PubMed  Google Scholar 

  22. Ando J, Tsuboi H, Korenaga R et al (1996) Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells. Biochem Biophys Res Commun 225:347–351

    Article  CAS  PubMed  Google Scholar 

  23. Osanai T, Okada S, Sirato K et al (2001) Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 104:3132–3136

    Article  CAS  PubMed  Google Scholar 

  24. Osanai T, Tomita H, Kushibiki M et al (2009) Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells. Cardiovasc Res 81:780–787

  25. Sen S, Tarazi RC, Khairallah PA et al (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35:775–781

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The project was supported by the National Natural Science Foundation of China (Grant No. 81200175), Qingdao Science and Technology Support Program [2011-2-3-2-(14)-nsh], and China Postdoctoral Science Foundation (2014M551872).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhiming Ge or Hongyan Dai.

Ethics declarations

Conflict of interest

T. He, A. Guan, Y. Shi, Z. Ge, and H. Dai state that there are no conflicts of interest.

All national guidelines on the care and use of laboratory animals have been followed and the necessary approval was obtained from the relevant authorities.

Additional information

T. He and A. Guan contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, T., Guan, A., Shi, Y. et al. Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy. Herz 40, 783–787 (2015). https://doi.org/10.1007/s00059-015-4301-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-015-4301-8

Keywords

Schlüsselwörter

Navigation